Cargando…

Construction and validation of a prognostic model for predicting clear cell renal cell carcinoma based on complement-related genes

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a highly heterogeneous tumor and is the most common subtype of renal cell carcinoma (RCC). Surgery is used to cure most early ccRCC, but the 5-year overall survival (OS) of ccRCC patients is far from satisfactory. Thus, new prognostic features a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Cheng, Sun, Ye, Di, Sichen, Wang, Hongru, Tian, Yijun, Wang, Chao, Cui, Xingang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170275/ https://www.ncbi.nlm.nih.gov/pubmed/37181236 http://dx.doi.org/10.21037/tau-23-187

Ejemplares similares

FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity
por: Dong, Keqin, et al.
Publicado: (2022)

Construction and validation of programmed cell death-based molecular clusters for prognostic and therapeutic significance of clear cell renal cell carcinoma
por: Tang, Yanlin, et al.
Publicado: (2023)

Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma
por: Han, Wenkai, et al.
Publicado: (2022)

Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma
por: Ma, Xuzhan, et al.
Publicado: (2023)

Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT/mTOR signaling pathway
por: Di, Sichen, et al.
Publicado: (2023)

Correction: Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma
por: Han, Wenkai, et al.
Publicado: (2022)

RNF43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma
por: ZHU, DAWEI, et al.
Publicado: (2022)

Systematic Construction and Validation of a Novel Macrophage Differentiation–Associated Prognostic Model for Clear Cell Renal Cell Carcinoma
por: Liu, Chen, et al.
Publicado: (2022)

Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma
por: Zhan, Chuanchuan, et al.
Publicado: (2021)

Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma
por: Wang, Zhan, et al.
Publicado: (2022)

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
por: Gan, Kai, et al.
Publicado: (2022)

Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients
por: Yang, Huiying, et al.
Publicado: (2020)

Construction and validation of a prognostic model for kidney renal clear cell carcinoma based on podocyte‐associated genes
por: Chen, Can, et al.
Publicado: (2022)

Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2022)

A metabolic reprogramming-related prognostic risk model for clear cell renal cell carcinoma: From construction to preliminary application
por: Zhang, Qian, et al.
Publicado: (2022)

Expression of CIDE proteins in clear cell renal cell carcinoma and their prognostic significance
por: Yu, Ming, et al.
Publicado: (2013)

The Construction and Validation of a new Predictive Model for Overall Survival of Clear Cell Renal Cell Carcinoma Patients with Bone Metastasis Based on Machine Learning Algorithm
por: Le, Yijun, et al.
Publicado: (2023)

Construction of five microRNAs prognostic markers and a prognostic model for clear cell renal cell carcinoma
por: Zhou, Qi, et al.
Publicado: (2021)

Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell Carcinoma
por: Shi, Zhiyuan, et al.
Publicado: (2022)

Identification and validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinoma
por: Deng, Qiong, et al.
Publicado: (2023)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Analyzing and validating the prognostic value and immune microenvironment of clear cell renal cell carcinoma
por: Ke, Jingwei, et al.
Publicado: (2022)

Combination of Hematology Indicators and Oncological Characteristics as a New Promising Prognostic Factor in Localized Clear Cell Renal Cell Carcinoma
por: Kang, Xiangpeng, et al.
Publicado: (2020)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation
por: Wang, Zhen-Da, et al.
Publicado: (2022)

Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma
por: Fan, ZhiXiang, et al.
Publicado: (2022)

Construction of a prognostic prediction model for renal clear cell carcinoma combining clinical traits
por: Weng, Yujie, et al.
Publicado: (2023)

Identification and validation of DLX4 as a prognostic and diagnostic biomarker for clear cell renal cell carcinoma
por: Wang, Jiawei, et al.
Publicado: (2023)

Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma
por: Wang, Chao, et al.
Publicado: (2021)

Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma
por: Sun, Jian-Xuan, et al.
Publicado: (2021)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Systematic Review: ClearCode 34 – A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Ghatalia, Pooja, et al.
Publicado: (2018)

Identification of subtypes of clear cell renal cell carcinoma and construction of a prognostic model based on fatty acid metabolism genes
por: Nie, Shiwen, et al.
Publicado: (2022)

Development and validation of the prognostic value of the immune-related genes in clear cell renal cell carcinoma
por: Liao, Zhuangyao, et al.
Publicado: (2021)

Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis
por: Zhou, Lu, et al.
Publicado: (2022)

Development and validation of prognostic nomogram for elderly patients with clear cell renal cell carcinoma based on the SEER database
por: Lin, Mingxin, et al.
Publicado: (2023)

Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics
por: Yang, Yiren, et al.
Publicado: (2023)

Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma
por: Wang, Yue, et al.
Publicado: (2018)

The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Kang, Weiting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5gksa1ucjuolu703vem0qgs87j